Dendritic cell phenotype in severe asthma reflects clinical responsiveness to glucocorticoids

By  

CLINICAL & EXPERIMENTAL ALLERGY, Vol. 48, Iss. 1, 2018-01 ,pp. : 13-22

John Wiley & Sons Inc

Access to resources Recommend Favorite

Oral corticosteroid sparing with omalizumab in severe allergic (IgE-mediated) asthma patients

By Siergiejko Zenon   ŚŚwiebocka Ewa   Smith Nicola   Peckitt Clare   Leo Jo   Peachey Guy   Maykut Robert  

Current Medical Research and Opinion, Vol. 27, Iss. 11, 2011-11 ,pp. : 2223-2228

Informa Healthcare

Access to resources Recommend Favorite

Effects of Corticosteroid on the Expression of Thymus and Activation-Regulated Chemokine in a Murine Model of Allergic Asthma

By  

International Archives of Allergy and Immunology, Vol. 137, Iss. 1, 2005-06 ,pp. : 60-68

Karger

Access to resources Recommend Favorite

Utility of serum periostin and free IgE levels in evaluating responsiveness to omalizumab in patients with severe asthma

By  

ALLERGY, Vol. 71, Iss. 10, 2016-10 ,pp. : 1472-1479

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effect of omalizumab on the need for rescue systemic corticosteroid treatment in patients with moderate-to-severe persistent IgE-mediated allergic asthma: a pooled analysis

By Busse William W.   Massanari Marc   Kianifard Farid   Geba Gregory P.  

Current Medical Research and Opinion, Vol. 23, Iss. 10, 2007-10 ,pp. : 2379-2386

Informa Healthcare

Access to resources Recommend Favorite